The Effect of a Breastfeeding Roadmap on Breastfeeding Self-Efficacy and Effective Breastfeeding in Primiparous Mothers.

Breastfeed MedJul 23, 2026 (epub)
Clinical ResearchObstetrics & GynecologyPediatrics

Ebru Bariş, Hediye Karakoç, Halime Esra Meram et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial investigated the effect of a breastfeeding roadmap on self-efficacy and effectiveness in 74 primiparous mothers. Results indicated significant improvements in both breastfeeding self-efficacy (F = 61.561, p < 0.001) and effectiveness (F = 39.572, p < 0.001) in the intervention group compared to the control group.

Key findings

  • The intervention group showed a significant increase in breastfeeding self-efficacy (F = 61.561, p < 0.001).
  • Breastfeeding effectiveness also significantly improved in the intervention group (F = 39.572, p < 0.001).
  • The breastfeeding roadmap was used in addition to routine education for the intervention group.
  • Data were collected using validated tools like the BSES-SF and LATCH.

Why it matters

Enhancing breastfeeding self-efficacy and effectiveness is crucial for primiparous mothers, as it can lead to better breastfeeding outcomes and maternal satisfaction. Evidence-based interventions like the breastfeeding roadmap can support healthcare providers in improving postpartum care.

Source

PubMed · PMID 42489220

Published in Breastfeed Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Obstetrics & Gynecology

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.